In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating ... The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is ...

On Tuesday, Piper Sandler maintained its optimistic stance on shares of Zura Bio Ltd. (NASDAQ: ZURA), reiterating an Overweight rating with a $26.00 price target. The firm's confidence in Zura Bio ...

On Monday, Piper Sandler adjusted its outlook on Wingstop (NASDAQ:WING) shares, reducing the price target to $300 from the previous $375, while maintaining a Neutral rating on the stock.

On Monday, ESSA Pharma (NASDAQ:EPIX) experienced a significant shift in stock rating and price target from Piper Sandler. The biopharmaceutical company was downgraded from Overweight to Neutral ...

On Tuesday, Piper Sandler reiterated its Overweight rating on shares of Glaukos Corporation (NYSE: NYSE:GKOS) with a steady price target of $140.00 after the company reported third-quarter results ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

Clay Stinnett, EVP and CFO will participate in the Piper Sandler 2024 East Coast Financial Services Conference to be held November 13th and 14th, and will participate in a series of meetings with ...

Piper Sandler raised the firm’s price target on Cigna (CI) to $394 from $392 and keeps an Overweight rating on the shares. The firm notes Cigna reported a pharmacy-led Q3 adjusted EPS beat and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...